Invaio

Invaio Sciences, Inc. is a multi-platform technology company headquartered in Cambridge, Massachusetts, with additional offices in Durham, North Carolina; Basel, Switzerland; and São Paulo, Brazil. Established in 2016, the company focuses on harnessing advanced sciences to address critical challenges in agriculture, nutrition, and the environment. Invaio's innovative technologies aim to reduce pesticide usage globally by enhancing the understanding of insect physiology and interdependent natural systems. By developing solutions that are both effective against pests and safe for beneficial species, Invaio seeks to create a positive impact on agriculture and human and animal health, positioning itself at the forefront of transformative practices in these fields.

Ignacio Martinez

President and CEO

1 past transactions

Peptyde Bio

Acquisition in 2023
Peptyde Bio is an Agtech startup focused on developing bio-fungicidal technology to combat fungal diseases. The company specializes in natural antimicrobial peptides (AMPs) derived from plants, positioning itself as a key supplier in this niche market. By leveraging these innovative compounds, Peptyde Bio aims to provide more affordable and effective treatment options for patients suffering from fungal infections.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.